![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Teresa Herbert
teresa_herbert@dfci.harvard.edu
617-632-5653
Dana-Farber Cancer Institute
Caption: Catherine Wu, M.D., and colleagues have published a study that shows how gene mutations shift and evolve over time in chronic lymphocytic leukemia (CLL). This evolution, they report, holds the key to understanding why CLL often recurs after treatment and helps explain why patients with a seemingly similar disease often don’t derive the same benefit from therapy and why therapy itself may speed the recurrence of the disease.
Credit: Sam Ogden
Usage Restrictions: None
Related news release: Study tracks leukemia's genetic evolution, may help predict disease course, tailor care
|